Briefing
|
- Pharmaceuticals Supply Chain Blockchain – Logistics firm DHL and professional services company Accenture released report on blockchain technology prototype for tracking pharmaceuticals supply chain, from development of medicines to reaching customers
- Features – Has nodes in six geographies for tracking pharmaceuticals across global supply chain, and can handle more than seven billion unique serial numbers and 1,500 transactions per second
- Shareable Across Stakeholders – Can be shared among stakeholders, including manufacturers, warehouses, distributors, pharmacies, hospitals, and doctors
- Addressing Drug Counterfeit – Aims to address proliferation of counterfeit drugs, which causes one million deaths per year, and makes up 30% of pharmaceuticals sold in emerging markets
- Advantages – Reduces tampering and error, while promoting greater drug safety and lower costs
- Other Blockchain Solutions – Report also explores blockchain use for asset management to improve transparency and traceability, as well as smart contracts which automatically facilitate and verify contracts without third parties
|
Accelerator
|
|
Market Disruption
|
|
Business Model and Practices
Business Model and Practices
|
|
Sector
|
Healthcare/Health Sciences
|
Organization
|
DHL International GmbH
|
Source
|
|
Original Publication Date
|
March 12, 2018
|